JPH0458467B2 - - Google Patents
Info
- Publication number
- JPH0458467B2 JPH0458467B2 JP12308384A JP12308384A JPH0458467B2 JP H0458467 B2 JPH0458467 B2 JP H0458467B2 JP 12308384 A JP12308384 A JP 12308384A JP 12308384 A JP12308384 A JP 12308384A JP H0458467 B2 JPH0458467 B2 JP H0458467B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- methanol
- alcohol
- solution
- under reduced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 claims description 5
- -1 3,6-dihydroxy-3-methoxycarbonyl-3,4-dihydro-2(1H)-quinolone Chemical compound 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000209094 Oryza Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000000043 antiallergic agent Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Landscapes
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12308384A JPS611666A (ja) | 1984-06-15 | 1984-06-15 | 新規２（１ｈ）−キノロン誘導体 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP12308384A JPS611666A (ja) | 1984-06-15 | 1984-06-15 | 新規２（１ｈ）−キノロン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS611666A JPS611666A (ja) | 1986-01-07 |
| JPH0458467B2 true JPH0458467B2 (enExample) | 1992-09-17 |
Family
ID=14851772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP12308384A Granted JPS611666A (ja) | 1984-06-15 | 1984-06-15 | 新規２（１ｈ）−キノロン誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS611666A (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015134359A1 (en) | 2014-03-06 | 2015-09-11 | The Procter & Gamble Company | Three-dimensional substrates |
| WO2017034796A1 (en) | 2015-08-26 | 2017-03-02 | The Procter & Gamble Company | Absorbent articles having three-dimensional substrates and indicia |
| TWI817867B (zh) * | 2022-12-15 | 2023-10-01 | 大江生醫股份有限公司 | 1,2,3,4-四氫喹啉類化合物用於改善動脈粥狀硬化的用途 |
-
1984
- 1984-06-15 JP JP12308384A patent/JPS611666A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS611666A (ja) | 1986-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH645386A5 (fr) | Saponine, procede pour sa preparation et medicaments contenant cette saponine. | |
| GB2115409A (en) | Novel crystal modifications of (+)-catechin | |
| JPH1072357A (ja) | 抗アレルギー剤 | |
| RU2088256C1 (ru) | Средство для комплексной терапии заболеваний "диквертин" и способ его получения | |
| JPH0458467B2 (enExample) | ||
| JP2732259B2 (ja) | 新規なアコニチン系化合物および鎮痛・抗炎症剤 | |
| CN109096232B (zh) | 一种联苄基二聚体类化合物及其从金钗石斛中提取分离的方法与应用 | |
| RU2240304C2 (ru) | Производные гиперфорина, их использование и препараты, содержащие эти производные | |
| CN111018877B (zh) | 一种土木香中倍半萜类衍生物、其制备方法及应用 | |
| LU82583A1 (fr) | Compositions pharmaceutiques contenant des extraits de lierre grimpant | |
| HU180710B (en) | Equipment for the isolation by extraction of natural terpenes active against psoriasis from leaves and rhizomes of fern and for preparing pharmaceutical compositions from the extract | |
| JPS6217598B2 (enExample) | ||
| RU2183966C1 (ru) | Состав биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий и способ получения биофлавоноидного комплекса сибларекс для биологически активных добавок, медицинских и химико-фармацевтических изделий | |
| HUT64233A (en) | Process for the production of chemotherapeutical agent of antitumourous effect, small toxicity and big selectivity originated of plants | |
| JP5675034B2 (ja) | デイジーから得られる中性脂質吸収抑制剤及びサポニン化合物並びにその用途 | |
| JPS58150584A (ja) | クワノン化合物 | |
| KR930701968A (ko) | 식물에서 추출된 항신생물 약제 및 그의 제조 방법 | |
| JP2674758B2 (ja) | リクイリチンの単離方法 | |
| CN111689972A (zh) | 一种替莫唑胺与橙皮素的共晶及其制备方法 | |
| CN113698380B (zh) | 木脂素类化合物及其制备方法和应用 | |
| EP1917260A2 (en) | Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method | |
| JP3006902B2 (ja) | モノテルペン配糖体 | |
| CN116283533A (zh) | 具有nlrp3抑制活性的鸡脚参酮a及其衍生物与应用 | |
| JPH024790A (ja) | 抗潰瘍剤 | |
| RU2671408C1 (ru) | Способ получения вещества, обладающего диуретической активностью |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |